NSAIDs inhibit αVβ3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis
Authors:
- 1 September 2001
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 7 (9) , 1041-1047
Abstract
Cyclooxygenase-2 (COX-2), a key enzyme in arachidonic acid metabolism, is overexpressed in many cancers. Inhibition of COX-2 by nonsteroidal anti-inflammatory drugs (NSAIDs) reduces the risk of cancer development in humans and suppresses tumor growth in animal models. The anti-cancer effect of NSAIDs seems to involve suppression of tumor angiogenesis, but the underlying mechanism is not completely understood. Integrin αVβ3 is an adhesion receptor critically involved in mediating tumor angiogenesis. Here we show that inhibition of endothelial-cell COX-2 by NSAIDs suppresses αVβ3-dependent activation of the small GTPases Cdc42 and Rac, resulting in inhibition of endothelial-cell spreading and migration in vitro and suppression of fibroblast growth factor-2–induced angiogenesis in vivo. These results establish a novel functional link between COX-2, integrin αVβ3 and Cdc42-/Rac-dependent endothelial-cell migration. Moreover, they provide a rationale to the understanding of the anti-angiogenic activity of NSAIDs.Keywords
This publication has 39 references indexed in Scilit:
- Vascular-specific growth factors and blood vessel formationNature, 2000
- Angiogenesis in cancer and other diseasesNature, 2000
- The role of cyclooxygenases in inflammation, cancer, and developmentOncogene, 1999
- The Role of Cyclooxygenase Inhibition in the Antineoplastic Effects of Nonsteroidal Antiinflammatory Drugs (Nsaids)Journal of Experimental Medicine, 1999
- Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)JNCI: Journal of the National Cancer Institute, 1998
- Cyclooxygenase in biology and diseaseThe FASEB Journal, 1998
- Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)Cell, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous PolyposisNew England Journal of Medicine, 1993
- Identification of a phorbol ester-repressible v-src-inducible gene.Proceedings of the National Academy of Sciences, 1989